Contract 75N93019C00028
Pai Life Sciences Inc · Department Of Health And Human Services · July 16, 2024
Pai Life Sciences Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 16, 2024 for $2.34 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Seattle, WA. It was awarded under a small business set-aside. It uses cost-plus contract pricing. If all options are exercised, the contract could reach $2.34 million.
Contract details
- PIID
- 75N93019C00028
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Seattle, WA
- First action
- July 16, 2024
Description
TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE CONTRACT.
Modification timeline
-
July 16, 2024Mod P00007 · Close Out$2.34M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019C00028?
Contract 75N93019C00028 is a federal contract awarded to Pai Life Sciences Inc by Department Of Health And Human Services on July 16, 2024 for $2.34 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N93019C00028?
Pai Life Sciences Inc won contract 75N93019C00028 from Department Of Health And Human Services.
How much is contract 75N93019C00028 worth?
Contract 75N93019C00028 has obligated $0 to date but carries a potential ceiling of $2.34 million if fully funded and all options are exercised.